secwatch.observer — SEC 8-K summary
======================================

Issuer:     RESMED INC (RMD)
CIK:        0000943819
Form:       8-K
Filed at:   2023-11-09T23:59:59+00:00
Accession:  0001193125-23-274543
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ResMed appoints new CPO, CMO, CRO; COO Douglas to retire Jan 1, 2024
--------------------------------------------------------------------

- Rob Douglas, President & COO, retires Jan 1, 2024; transitions to special advisor to CEO immediately.
- Justin Leong named Chief Product Officer, Katrin Pucknat as CMO, Mike Fliss as CRO, effective immediately.
- Lucile Blaise moves from president sleep & respiratory care to SVP strategy & business development.
- New operating model sets product-led, customer-centric, brand-enhanced focus to accelerate profitable growth.
- Former CTO Urvashi Tyagi becomes special advisor to CPO through Jan 1, 2024; consulting through Dec 31, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/943819/000119312523274543/0001193125-23-274543-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/943819/000119312523274543/d287548d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-274543

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer